Patents by Inventor Hong Jin

Hong Jin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130014431
    Abstract: A fuel composition and the process of making the fuel composition are described. More specifically, a novel biomass derived low sulfur bunker fuels composition and the method of making thereof. Embodiment of the invention discloses a novel low sulfur bunker fuels composition derived from blending various bio-oil with other heavy residual fuel oils and distillates where final sulfur content and carbon intensity is controlled by the ratio of bio-oil to other heavy residual fuel oils and distillates. Embodiment of the invention also discloses a process of making a novel biomass derived low sulfur bunker fuels by blending various bio-oil with other heavy residual fuel oils and distillates.
    Type: Application
    Filed: May 21, 2012
    Publication date: January 17, 2013
    Applicant: PHILLIPS 66 COMPANY
    Inventors: Hong Jin, Cory B. Phillips, Daren E. Daugaard, Kristi A. Fjare, Robert A. Levine
  • Patent number: 8354114
    Abstract: Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture are provided. Bi-directional expression vectors for use in a multi-plasmid influenza virus expression system are provided. Additionally, the invention provides methods of producing influenza viruses with enhanced ability to replicate in embryonated chicken eggs and/or cells (e.g., Vero and/or MDCK) and further provides influenza viruses with enhanced replication characteristics.
    Type: Grant
    Filed: October 17, 2006
    Date of Patent: January 15, 2013
    Assignee: Medimmune, LLC
    Inventors: Bin Lu, Hong Jin
  • Publication number: 20120308602
    Abstract: The present invention relates to genetically engineered recombinant respiratory syncytial viruses and viral vectors which contain deletions of various viral accessory gene(s) either singly or in combination. In accordance with the present invention, the recombinant respiratory syncytial viral vectors and viruses are engineered to contain complete deletions of the M2-2, NS1, NS2, or SH viral accessory genes or various combinations thereof. In addition, the present invention relates to the attenuation of respiratory syncytial virus by mutagenisis of the M2-1 gene.
    Type: Application
    Filed: June 5, 2012
    Publication date: December 6, 2012
    Applicant: MedImmune, LLC
    Inventors: Hong Jin, Roderick Tang, Shengqiang Li, Martin Bryant, David Kirkwood Clarke, Peter Palese
  • Publication number: 20120288521
    Abstract: Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture are provided. Bi-directional expression vectors for use in a multi-plasmid influenza virus expression system are provided. Additionally, the invention provides methods of producing influenza viruses with enhanced ability to replicate in embryonated chicken eggs and/or cells (e.g., Vero and/or MDCK) and further provides influenza viruses with enhanced replication characteristics. A method of producing a cold adapted (ca) influenza virus that replicates efficiently at, e.g., 25° C. (and immunogenic compositions comprising the same) is also provided.
    Type: Application
    Filed: November 15, 2011
    Publication date: November 15, 2012
    Applicant: MEDIMMUNE, LLC
    Inventors: Erich Hoffmann, Hong Jin, George Kemble, Zhongying Chen
  • Publication number: 20120282673
    Abstract: The present invention provides recombinant respiratory syncytial viruses that have an attenuated phenotype and that comprise one or more mutations in the viral P, M2-1 and/or M2-2 proteins, as well as live attenuated vaccines comprising such viruses and nucleic acids encoding such viruses. Recombinant RSV P, M2-1 and M2-2 proteins are described. Methods of producing attenuated recombinant RSV, and methods of quantitating neutralizing antibodies that utilize recombinant viruses of family Paramyxoviridae, are also provided.
    Type: Application
    Filed: May 17, 2012
    Publication date: November 8, 2012
    Applicant: Medlmmune, LLC
    Inventors: Hong JIN, Robert Brazas, Bin Lu
  • Publication number: 20120263744
    Abstract: The complete polynucleotide sequence of the human respiratory syncytial virus subgroup B strain 9320 genome is provided. Proteins encoded by this polynucleotide sequence are also provided. Isolated or recombinant RSV (e.g., attenuated recombinant RSV), nucleic acids, and polypeptides, e.g., comprising mutations in the attachment protein G, are also provided, as are immunogenic compositions comprising such isolated or recombinant RSV, nucleic acids, and polypeptides. Related methods are also described.
    Type: Application
    Filed: April 17, 2012
    Publication date: October 18, 2012
    Applicant: MedImmune, LLC
    Inventors: Xing Cheng, Hyun Jung Park, Hong Jin
  • Publication number: 20120244600
    Abstract: Polypeptides, polynucleotides, methods, compositions, and vaccines comprising influenza hemagglutinin and neuraminidase variants are provided.
    Type: Application
    Filed: December 1, 2011
    Publication date: September 27, 2012
    Applicant: MedImmune, LLC
    Inventor: Hong JIN
  • Publication number: 20120100169
    Abstract: The present invention relates to a pharmaceutical vaccine composition for a human cervical cancer, comprising: (a) (i) a L1 virus-like particle (VLP) of human papillomavirus (HPV) type 16, a L1 VLP of HPV type 18, or a combination thereof; and (ii) a deacylated non-toxic lipooligosaccharide (LOS); and (b) a pharmaceutically acceptable carrier; and a method for preparing a human papillomavirus (HPV) L1 virus-like particle (VLP). The pharmaceutical vaccine composition of the present invention is in both Th1-type immune response (cellular immunity) and Th2-type immune response (humoral immunity) against HPV more excellent than Cervrix™ and Gardasil™, exhibiting a superior efficacy as a vaccine for a human cervical cancer.
    Type: Application
    Filed: October 20, 2009
    Publication date: April 26, 2012
    Applicant: Eyegene Inc.
    Inventors: Hong-Jin Kim, Na Gyong Lee, Yang-Je Cho, Jin-Wook Jang, Hyoung Jin Kim, Kwang Sung Kim
  • Patent number: 8163530
    Abstract: The complete polynucleotide sequence of the human respiratory syncytial virus subgroup B strain 9320 genome is provided. Proteins encoded by this polynucleotide sequence are also provided. Isolated or recombinant RSV (e.g., attenuated recombinant RSV), nucleic acids, and polypeptides, e.g., comprising mutations in the attachment protein G, are also provided, as are immunogenic compositions comprising such isolated or recombinant RSV, nucleic acids, and polypeptides. Related methods are also described.
    Type: Grant
    Filed: July 23, 2009
    Date of Patent: April 24, 2012
    Assignee: MedImmune, LLC
    Inventors: Xing Cheng, Hyun Jung Park, Hong Jin
  • Publication number: 20120083189
    Abstract: A pad conditioning disk, a pre-conditioning unit, and a CMP apparatus having the same are provided. The pad conditioning disk includes a base in which mountain-type tips and valley-type grooves are repeatedly connected to each other, and a cutting layer formed on the base layer. The cutting layer including conditioning particles deposited on surfaces of the tips and grooves. A surfaces roughness of conditioning particles deposited on the surfaces of the tips is less than a surface roughness of conditioning particles deposited on the surfaces of the grooves.
    Type: Application
    Filed: September 23, 2011
    Publication date: April 5, 2012
    Inventors: Jae-Kwang Choi, Hong-Jin Kim, Keon-Sik Seo, Sol Han, Kun-Tack Lee, Byoung-Ho Kwon
  • Publication number: 20120043474
    Abstract: The present disclosure relates to laser processing and a laser processing apparatus for processing materials using laser. Processing performed after loading a wafer on a work stage and a laser processing apparatus for implementing such processing, among others, are disclosed. The laser processing includes loading a wafer on a work stage; determining the number of chips formed on the wafer loaded on the work stage, performing chip defect inspection and aligning the wafer while moving the work stage; measuring a height of a surface of the wafer loaded on the work stage using a displacement sensor; monitoring output power of a processing laser using a power meter; and shifting the work stage while irradiating a laser beam on the wafer to process the wafer.
    Type: Application
    Filed: October 28, 2010
    Publication date: February 23, 2012
    Applicants: QMC CO., LTD.
    Inventors: Beng So RYU, Hong-Jin JUNG, Byong-Shik LEE, Bum-Joong KIM, Hyeon-Sam JANG, Hark-Yong KIM, Jong-Ho KWAK, Young-Yong KIM, Sun-Young HONG
  • Patent number: 8114415
    Abstract: Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture are provided. Bi-directional expression vectors for use in a multi-plasmid influenza virus expression system are provided. Additionally, the invention provides methods of producing influenza viruses with enhanced ability to replicate in embryonated chicken eggs and/or cells (e.g., Vero and/or MDCK) and further provides influenza viruses with enhanced replication characteristics. A method of producing a cold adapted (ca) influenza virus that replicates efficiently at, e.g., 25° C. (and immunogenic compositions comprising the same) is also provided.
    Type: Grant
    Filed: October 20, 2008
    Date of Patent: February 14, 2012
    Assignee: Medimmune, LLC
    Inventors: Erich Hoffmann, Hong Jin, Bin Lu, Gregory Duke, George Kemble, Zhongying Chen
  • Publication number: 20120020997
    Abstract: Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture are provided. Bi-directional expression vectors for use in a multi-plasmid influenza virus expression system are provided.
    Type: Application
    Filed: August 19, 2011
    Publication date: January 26, 2012
    Inventors: Erich Hoffman, Hong Jin, Bin Lu, Greg Duke, George Kemble
  • Patent number: 8097459
    Abstract: In certain aspects, the present invention provides methods for increasing the replication capacity of influenza viruses in hens' eggs and/or cell culture, recombinant and/or reassortant influenza viruses with increased replication capacity, and immunogenic and vaccine compositions comprising such recombinant and/or reassortant influenza viruses. In other aspects, the invention further provides nucleic acids encoding influenza genes associated with increased replication capacity, expression vectors comprising the nucleic acids of the invention, methods for making influenza viruses with increased replication capacity, and kits useful for practice of the methods.
    Type: Grant
    Filed: September 1, 2009
    Date of Patent: January 17, 2012
    Assignee: Medimmune, LLC
    Inventors: Hong Jin, Bin Lu
  • Patent number: 8088393
    Abstract: Polypeptides, polynucleotides, methods, compositions, and vaccines comprising influenza hemagglutinin and neuraminidase variants are provided.
    Type: Grant
    Filed: June 24, 2010
    Date of Patent: January 3, 2012
    Assignee: MedImmune, LLC
    Inventor: Hong Jin
  • Patent number: 8049956
    Abstract: The present invention relates to an OPCPA apparatus. The OPCPA of the present invention includes an optical pulse stretcher (100) for outputting chirped laser light using odd-order dispersion (third-order dispersion is mainly used). A pump laser (200) outputs pump laser light. An OPA unit (300) receives the pump laser light and the chirped laser light (signal), amplifies the signal using the pump laser light, and generates an idler. An optical signal separation unit (400) separates output light of the OPA unit into the signal, the idler, and remaining light (pump). An optical pulse compressor (600) compensates for pulse chirping caused by odd-order dispersion that is imparted by the optical pulse stretcher, thus temporally compressing the signal and the idler, which overlap each other.
    Type: Grant
    Filed: January 29, 2007
    Date of Patent: November 1, 2011
    Assignee: Korea Advanced Institute of Science and Technology
    Inventors: Hong Jin Kong, Dong Won Lee, Young Ho Park, Jin Woo Yoon, Mi Jung Cho, Jae Sung Shin, Byoung Goo Jeon
  • Patent number: D647087
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: October 18, 2011
    Assignee: Hon Hai Precision Industry Co., Ltd.
    Inventors: Yun-Lung Chen, Hong-Jin Wu, Qun Wang
  • Patent number: D647896
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: November 1, 2011
    Assignee: Hon Hai Precision Industry Co., Ltd.
    Inventors: Yun-Lung Chen, Hong-Jin Wu, Qun Wang
  • Patent number: D647908
    Type: Grant
    Filed: December 24, 2010
    Date of Patent: November 1, 2011
    Assignee: Hon Hai Precision Industry Co., Ltd.
    Inventors: Yun-Lung Chen, Hong-Jin Wu, Song-Tao Xie
  • Patent number: D654496
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: February 21, 2012
    Assignee: Hon Hai Precision Industry Co., Ltd.
    Inventors: Yun-Lung Chen, Hong-Jin Wu, Qun Wang